Back to Trades
Sell4
VERTEX PHARMACEUTICALS INC / MA
VRTX
Total Value
$1.5M
Net $930.5K sold
Sales
$930.5K
1 transaction
Company Information
- Company Name
- VERTEX PHARMACEUTICALS INC / MA
- Ticker Symbol
- VRTX
- CIK
- 0000875320
Insider Information
- Name
- Bunnage Mark E.
- Role
- EVP, Chief Scientific Officer
- Location
- BOSTON, MA
Officer
Filing Details
- Filing Date
- Feb 12, 2026
- Transaction Date
- Feb 10, 2026
- Accession Number
- 0000875320-26-000044
- Form Type
- 4
- Net Trading Amount
- -$930.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Common Stock | 1,127 | $468.41 | Tax Withholding | $527.9K |
| Feb 11, 2026 | Common Stock | 2,021 | $460.43 | Sale | $930.5K |
Footnotes
- (F1)Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.